|
⚲
|
| Keyboard |
| Brooke Private Equity Associates Management LLC
✚
|
|
|---|---|
| CRD # | 156772 |
| SEC # | 801-74252 |
| CIK # | |
| AUM | 1,942.8 M (2026-06-29) |
| Employees | 19 (53% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 617-227-3160 |
| Address | 100 Federal Street Boston, MA 02110 |
| Source | [IAPD] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/26/2026) [Brochure] |
|---|
ITEM 5. FEES AND COMPENSATION BPEA charges management fees to the Funds for its advisory services and also receives performance- based fees from certain Funds as described in Item 6 of this Brochure. The amount and terms of payment of the management fees and performance based fees charged to each Fund are determined through negotiations with the investors of that Fund at the Fund’s inception. BPEA has the sole discretion to negotiate fee arrangements with clients, based on, among other things, asset size and affiliation with a third party adviser. Management fees and performance-based fees are calculated by the Funds and paid to BPEA under the terms of their limited partnership agreements, investment advisory agreements or other similar agreements. Generally, the management fees range from 0.65% to 1.25% of the total capital committed to the Fund by investors. For most Funds, after several years of existence the management fees are reduced by some percentage and certain Funds’ management fees have been reduced to zero. The payment schedule for management fees varies by Fund. Typically management fees are paid quarterly in advance, but they also may be paid on a monthly basis, under the terms of the limited partnership agreements, investment advisory agreements or other similar agreements. In addition to paying management fees and performance-based fees, the Funds also pay or reimburse BPEA for expenses relating to the Funds’ formation, investment activities and ongoing operations, including any brokerage fees incurred in connection with transactions in securities owned by the Funds. The Funds bear fees, costs and expenses as specified in each Fund’s governing documents, which include, but are not limited to the applicable private placement memorandum, limited partnership agreement or similar organizational document or management agreement, side letter or fee agreement. Refer to Item 12 of this Brochure for a description of BPEA’s brokerage practices. In some cases portfolio companies may also pay to BPEA or its affiliates transaction fees, deal monitoring fees, break-up fees, directors’ fees or fees for business services provided by BPEA or its affiliates. The terms of the partnership agreements of the Funds generally provide that the management fees otherwise payable to BPEA by a Fund will be reduced by a negotiated percentage of the Fund’s share of any transaction fees, deal monitoring fees, break-up fees or directors’ fee received by BPEA. Additionally, while not exercised to date, the partnership agreements of certain Funds permit BPEA to retain any fees received for providing business services such as assistance with technology transfers or mergers and acquisitions; assistance in connection with the acquisition, disposition or reorganization of a company; debt syndication; providing full-time or part-time management or operating personnel; providing investment banking services with respect to specific transactions; or developing business plans and other presentations. BPEA acts as a sub-adviser for NYSCRF Pioneer Co-Investment Fund, LP (“Pioneer”) and representatives of BPEA sit on the investment committee of the general partner of Pioneer. Pioneer no longer makes new investments. In connection with entering into the sub-adviser relationship for Pioneer, BPEA agrees to provide certain administrative and other back office support services to Farol Investment Advisers LP (“Farol”), the adviser to Pioneer, pursuant to an Infrastructure Services Agreement. As compensation for BPEA’s services to Farol pursuant to the Infrastructure Services Agreement and to the general partner of Pioneer, BPEA receives a percentage of the management fee paid by Pioneer to Farol or its affiliates. Affiliates of BPEA also may receive performance-based compensation from the general partner of Pioneer contingent upon Pioneer achieving certain investment performance hurdles. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/26/2026) [Brochure] |
|---|
ITEM 7. TYPES OF CLIENTS BPEA provides investment advice to Funds generally organized as limited partnerships in which an affiliate of BPEA serves as the general partner. Investors in the Funds typically include high net worth individuals, trusts, pension plans, corporations, endowments, and foundations. For most of the Funds BPEA has required a minimum investment amount, typically at least $1 million, although investments below the established minimum are permitted. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | BPEA Cayman VII LP | [2025-03-28] | 42.2 M | 58.8 M |
| Filed 2025-09-29 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Finder's Fee $150,000 · Revenue Decline to Disclose | ||||
| PE | BPEA VII LP | [2025-03-28] | 233.7 M | 269.3 M |
| Filed 2025-09-29 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | BPEA Strategic Healthcare II LP | [2023-03-31] | 378.3 M | 426.8 M |
| Filed 2025-07-14 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Finder's Fee $2,017,500 · Revenue Decline to Disclose | ||||
| PE | BPEA Cayman VI LP | [2022-03-30] | 44.7 M | 68.6 M |
| Filed 2023-02-14 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | BPEA VI LP | [2022-03-30] | 279.2 M | 362.6 M |
| Filed 2023-02-14 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | BPEA Cayman V LP | [2020-03-27] | 30.6 M | 34.3 M |
| Filed 2020-08-11 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | BPEA V LP | [2020-03-27] | 210.7 M | 234.0 M |
| Filed 2020-08-11 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | BPEA Strategic Healthcare I-B LP | [2019-03-29] | 305.8 M | 410.0 M |
| Filed 2020-04-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | BPEA Cayman IV LP | [2018-03-21] | 26.6 M | |
| Filed 2017-04-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | BPEA IV LP | [2018-03-21] | 167.0 M | |
| Filed 2017-04-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | BPEA Cayman III LP | [2015-03-31] | 11.3 M | 6.5 M |
| Filed 2015-06-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | BPEA III LP | [2015-03-31] | 99.1 M | 45.9 M |
| Filed 2015-06-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | BPEA Life Sciences Fund I LP | 2012-02-15 | 2.5 M | |
| PE | BPEA Small Buyout and Growth Fund I LP | [2012-02-15] | 36.6 M | 6.6 M |
| Filed 2012-03-09 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Brooke Private Equity Advisors Cayman Fund I-A LP | 2012-02-15 | 0.0 M | |
| PE | Brooke Private Equity Advisors Cayman Fund II LP | 2012-02-15 | 0.0 M | |
| PE | Brooke Private Equity Advisors Fund I-A LP | 2012-02-15 | 1.9 M | |
| PE | Brooke Private Equity Advisors Fund I D LP | 2012-02-15 | 0.1 M | |
| PE | Brooke Private Equity Advisors Fund I F LP | 2012-02-15 | 0.6 M | |
| PE | Brooke Private Equity Advisors Fund II D LP | 2012-02-15 | 0.1 M | |
| PE | Brooke Private Equity Advisors Fund II F LP | 2012-02-15 | 0.7 M | |
| PE | Brooke Private Equity Advisors Fund II LP | 2012-02-15 | 7.4 M | |
| PE | Vectis Healthcare & Life Sciences Fund II LP | [2012-02-15] | 70.3 M | 20.1 M |
| Offered $175,000,000 · Filed 2009-08-12 (D/A) · Exemption 506, 3(c), 3(c)(1) · Remaining $104,670,330 · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Vectis Life Sciences Fund I LP | 2012-02-15 | 4.5 M | |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 14 | 1,942.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 14 | 1,942.8 |
| By Discretionary | ||
| Discretionary | 14 | 1,942.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 14 | 1,942.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 194.9 | |
| United States Persons | 1,748.0 | |
| Total | 14 | 1,942.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| General Partner Bpeam VI LLC | Promoter | 2 | 1 | |
| General Partner Bpea III GP LP | Promoter | 2 | 1 | |
| Christopher Austen | Executive Officer | 2 | 1 | |
| General Partner Bpeam IV LLC | Promoter | 2 | 1 | |
| General Partner of The General Partner Brooke Private Equity Management III LLC | Promoter | 2 | 1 | |
| John Brooke | Executive Officer | 2 | 1 | |
| General Partner Bpeam V LLC | Promoter | 2 | 1 | |
| Stephen Byers | Executive Officer | 1 | 1 | |
| General Partner Bpea Sbg GP LP | Promoter | 1 | 1 | |
| General Partner of The General Partner Bpea Sbg GP LLC | Promoter | 1 | 1 | |
| View All | ||||
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.3B |
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
FIC Partners Management LP
✚
|
TX | 1,967.0 M |
|
Brynwood Partners Management LLC
✚
|
CT | 1,964.5 M |
|
Ocean Avenue Capital Partners LP
✚
|
CA | 1,964.2 M |
|
Behrman Brothers Management Company LP
✚
|
NY | 1,948.2 M |
|
Capital Z Partners Management LLC
✚
|
FL | 1,944.7 M |
|
Lorient Capital Management LLC
✚
|
FL | 1,944.5 M |
|
Entrepreneurial Equity Partners LP
✚
|
IL | 1,932.1 M |
|
Comvest PE Advisors LLC
✚
|
FL | 1,920.5 M |
|
Legalist Inc
✚
|
CA | 1,915.1 M |
|
Carousel Capital Management Company LP
✚
|
NC | 1,912.8 M |